Company intelligence / Profile preview
PersonGen Anke Cellular Therapeutics
Hefei, Anhui, China
- Ownership
- Private
- Development stage
- Other
01
Overview
PersonGen Anke Cellular Therapeutics is a high-tech joint venture established by PersonGen Biotherapeutics and Anhui Anke Biotechnology. The company focuses on the development and commercialization of innovative Chimeric Antigen Receptor T-cell (CAR-T) therapies for both hematological malignancies and solid tumors. Its lead program, PA3-17, is a CD19-targeted CAR-T cell injection that has advanced into pivotal clinical trials in China for relapsed or refractory B-cell acute lymphoblastic leukemia. The company operates a large-scale, state-of-the-art GMP manufacturing facility in Hefei, designed to support the clinical and commercial supply of advanced cellular immunotherapies.
- Therapeutic areas
- Oncology
- Modalities
- CAR-T cell therapyCell therapy
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
PersonGen BiotherapeuticsAnhui Anke Biotechnology (Group) Co., Ltd.
Beyond the preview
Go deeper on PersonGen Anke Cellular Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PersonGen Anke Cellular Therapeutics.